- Home
- NGS vs INBX Comparison
NGS vs INBX Comparison
Compare NGS & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGS
- INBX
- Stock Information
- Founded
- NGS 1998
- INBX 2010
- Country
- NGS United States
- INBX United States
- Employees
- NGS N/A
- INBX N/A
- Industry
- NGS Oilfield Services/Equipment
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- NGS Energy
- INBX Health Care
- Exchange
- NGS Nasdaq
- INBX Nasdaq
- Market Cap
- NGS 241.7M
- INBX 218.9M
- IPO Year
- NGS 2002
- INBX 2020
- Fundamental
- Price
- NGS $24.72
- INBX $13.92
- Analyst Decision
- NGS Strong Buy
- INBX Hold
- Analyst Count
- NGS 2
- INBX 1
- Target Price
- NGS $26.50
- INBX N/A
- AVG Volume (30 Days)
- NGS 67.9K
- INBX 71.1K
- Earning Date
- NGS 11-14-2024
- INBX 11-14-2024
- Dividend Yield
- NGS N/A
- INBX N/A
- EPS Growth
- NGS 605.21
- INBX N/A
- EPS
- NGS 1.28
- INBX 119.38
- Revenue
- NGS $152,305,000.00
- INBX $1,568,000.00
- Revenue This Year
- NGS $30.81
- INBX N/A
- Revenue Next Year
- NGS $13.48
- INBX N/A
- P/E Ratio
- NGS $19.17
- INBX $0.12
- Revenue Growth
- NGS 41.72
- INBX 19.24
- 52 Week Low
- NGS $13.70
- INBX $10.80
- 52 Week High
- NGS $28.50
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- NGS 45.69
- INBX 38.33
- Support Level
- NGS $23.70
- INBX $14.53
- Resistance Level
- NGS $26.08
- INBX $15.24
- Average True Range (ATR)
- NGS 1.16
- INBX 0.72
- MACD
- NGS -0.49
- INBX -0.10
- Stochastic Oscillator
- NGS 22.42
- INBX 19.16
About NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.